🇺🇸 FDA
Patent

US 6787636

Modified serum albumin with reduced affinity for nickel and copper

expired A61KA61K2800/86A61K47/42

Quick answer

US patent 6787636 (Modified serum albumin with reduced affinity for nickel and copper) held by New Century Pharmaceuticals, Inc. expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
New Century Pharmaceuticals, Inc.
Grant date
Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2800/86, A61K47/42, A61K8/345, A61K8/64